A new insulin pen will appear before diabetics.

Two Mexican scientists worldwide on Monday morning jointly announced the development of a soluble insulin pen that provides patients with type 1 diabetes and two simple ways to strengthen rechargeable analogues in treatment. It is pointed out that this drug should be successfully applied to patients in the country and other countries.
In the case of Mexico City, experts today announced the effects of diabetes and the benefits of the drug.
The head of the Endocrinology Department of the Mexican General Hospital said diabetes became blind, aggregated and renal failure, with only 13% of the major causes, requiring patients to be treated with insulin and avoid complications.
He said, "we must break the myth of insulin, because there are complications."